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        Naturally occurring regulatory T (T reg) cells  —
  once a highly controversial topic  —  have now 
gained wide acceptance as playing a critical role 
in the maintenance of self-tolerance. T reg cells 
suppress immune activation in a dominant man-
ner and are characterized by the expression of the 
transcription factor FoxP3 (  1  –  3  ). The importance 
of T reg cells in immune homeostasis is best illus-
trated by the development of severe autoimmune 
diseases in both mice and humans with genetic 
defi  ciencies of FoxP3 (  4, 5  ). One question that 
remains poorly understood is how a very small 
number of antigen-specifi  c T reg cells can be 
so effi   cient in exerting their suppressive eff  ect 
in vivo (  6  ). One possibility is that T reg cell func-
tion can be activated by cytokines such as IL-2 
alone (  7  ). Alternatively, T reg cells can induce a 
suppressive phenotype in potential eff  ector cells 
thereby expanding the pool of suppressive cells. 
  The term   “  infectious tolerance  ”   was origi-
nally coined by Gershon and Kondo and referred 
to suppression of naive lymphocyte popula-
tions by cells with regulatory function (  8  ). This 
concept was later expanded upon by Qin et al. 
(  9  ) and is now used to describe a process where 
a tolerance-inducing state is transferred from 
one cell population to another. Previous stud-
ies have demonstrated a role for T reg cells in 
the long-term acceptance of allogeneic trans-
plants and the induction of infectious tolerance 
against these grafts (  10  ). Several in vitro studies 
have demonstrated that T reg cells can induce 
suppressive CD4  +   T cells, but the exact nature 
of these cells is unclear, including whether they 
express FoxP3 or not (  11  –  13  ). The demonstration 
that TGF-      is a potent inducer of FoxP3 ex-
pression (  14  ) and T reg cell function in vitro and 
in vivo (  14, 15  ), together with recent studies dem-
onstrating that T reg cell production of TGF-      
is required for protection against autoimmune 
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  CD4  +  FoxP3  +   regulatory T (T reg) cells comprise a separate lineage of T cells that are essen-
tial for maintaining immunological tolerance to self. The molecular mechanism(s) by which 
T reg cells mediate their suppressive effects remains poorly understood. One molecule that 
has been extensively studied in T reg cell suppression is transforming growth factor (TGF)-    , 
but its importance remains controversial. We found that TGF-     complexed to latency-
associated peptide (LAP) is expressed on the cell surface of activated but not resting T reg 
cells. T reg cell LAP  –  TGF-     plays an important role in the suppression of the proliferation 
of activated T cells, but it is not required for the suppression of naive T cell activation. 
More importantly, T reg cell  –  derived TGF-     could generate de novo CD4  +  FoxP3  +   T cells in 
vitro from naive precursors in a cell contact  –  dependent, antigen-presenting cell  –  independent 
and       V   integrin  –  independent manner. The newly induced CD4  +  FoxP3  +   T cells are suppres-
sive both in vitro and in vivo. Transfer of activated antigen-specifi  c T reg cells with naive 
antigen-specifi  c responder T cells to normal recipients, followed by immunization, also 
results in induction of FoxP3 expression in the responder cells. T reg cell  –  mediated 
generation of functional CD4  +  FoxP3  +   cells via this TGF-      –  dependent pathway may repre-
sent a major mechanism as to how T reg cells maintain tolerance and expand their suppres-
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CD4  +  CD25  +   T cells (95% FoxP3  +  ) were cultured with APCs 
and anti-CD3 or plate-bound anti-CD3 in the presence of 
rLAP, they were no longer completely anergic (  Fig. 1 D  ). 
However, the addition of rLAP failed to reverse the anergic 
state of CD4  +  CD25  +  FoxP3  +   T cells isolated from FoxP3 
GFP knock-in mice (  Fig. 1 E  ), suggesting that rLAP allowed 
CD4  +  CD25  +  FoxP3         T cells to produce IL-2 and proliferate 
even in the presence of 20 times more T reg cells. The spe-
cifi  c loss of suppression of CD4  +  CD25  +  FoxP3         T cells was 
also seen when rLAP is added to the standard in vitro sup-
pression assays, which resulted in a modest but reproducible 
increase in eff  ector cell proliferation only when CD4  +  CD25  +   
T cells (  Fig. 1 F  ), but not CD4  +  CD25  +  FoxP3  +   T cells, were 
the source of the T reg cells. Thus, membrane-bound or po-
tentially soluble TGF-      plays a role in T reg cell suppression 
of activated CD4  +  CD25  +  FoxP3         T cells, but it is not needed 
for T reg cells to suppress naive T cells. 
disease (  16  ), raised the possibility that one potential mecha-
nism of action of T reg cells is to induce T reg cells de novo 
from T-naive precursors in a TGF-       –  dependent manner, thus 
generating infectious tolerance. In this study, we demonstrate 
that T reg cells directly confer infectious tolerance by inducing 
new CD4  +  FoxP3  +   T cells and defi  ne the mechanisms they use 
to do so. 
    RESULTS AND DISCUSSION   
  Previous studies have demonstrated that the TGF-      propep-
tide, latency-associated peptide (LAP), and thus presumably 
TGF-      are expressed on the surface of T reg cells, but the 
kinetics of LAP expression remain controversial (  17  –  19  ). 
Flow cytometric analysis of mouse lymph node cells demon-
strated that FoxP3  +   T cells do not express LAP under normal 
steady-state conditions, whereas a small subpopulation of 
non-CD4  +   T cells stained positive for LAP (  Fig. 1 A   and un-
published data).   After activation, T reg cells but not conven-
tional T cells expressed LAP on their cell surface (  Fig. 1 B  ). 
To determine if T reg cells also expressed active TGF-      (free 
from LAP) on their surface, we incubated activated T reg 
cells with recombinant LAP (rLAP) for 2 h at 4  °  C and then 
stained them for LAP. If free TGF-      was present on the sur-
face, it should be able to bind LAP resulting in increased LAP 
staining. No increase in the intensity of the LAP staining was 
seen, indicating that there is no active free TGF-      available 
on the cell surface (  Fig. 1 C  ). Staining of activated T cells 
with anti  –  TGF-      antibodies confi  rmed the lack of free TGF-      
on the cell surface of these cells (unpublished data). Similar 
results were observed with human T reg cells. Freshly explanted 
human peripheral blood CD4  +  FoxP3  +   T cells did not express 
LAP (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20080308/DC1), whereas 5% of CD4  +  FoxP3         T cells 
appeared to be LAP  +  . A marked increase of LAP expression 
was apparent on T reg cells already after 12 h of activation 
(Fig. S1), and almost all FoxP3  +   T cells were LAP  +   after 60 h 
of activation. Thus, it appears that LAP expression correlates 
with the suppressive function of T reg cells, as the FoxP3  +   
T cells derived from human CD4  +  CD25  +   T cells are sup-
pressive, whereas the FoxP3  +   T cells derived from human 
CD4  +  CD25         T cells, in contrast to mouse, fail to express a 
suppressive phenotype (  20  –  23  ). 
  The role of TGF-      in T reg cell suppression has been ex-
tensively studied, but its importance remains controversial 
(  16  –  19, 24  –  26  ). Our laboratory and others have previously 
reported that CD4  +  CD25  +   T cells can mediate suppressor 
function both in vitro and in vivo in the absence of TGF-      
(  24  –  26  ). The results presented above that T reg cells express 
cell surface LAP in an activation-dependent manner prompted 
us to reexamine the role of TGF-      in the anergic state of T 
reg cells and in T reg cell  –  mediated suppression. To deter-
mine if TGF-      plays any role in the anergic state of T reg 
cells, we used rLAP as a TGF-      inhibitor. We chose LAP as 
an inhibitor because it directly binds active TGF-      and could 
also potentially block the binding site of LAP  –  TGF-      com-
plexes to TGF-       –  activating factors. When highly purifi  ed 
    Figure 1.         LAP is expressed by activated T reg cells, and TGF-     is 
required to suppress CD4  +  CD25  +  FoxP3        T cells.   (A) Expression of LAP 
and FoxP3 on freshly isolated lymph node cells from C57BL/6 mice. 
(B) CD4  + CD25        (thick line histogram) and CD4  + CD25 +   T cells (thin line 
histogram) were activated for 3 d with plate-bound anti-CD3 and IL-2 
and analyzed for LAP expression. Isotype control is depicted with a solid 
gray histogram. (C) Activated CD4  + CD25 +   T cells were incubated with 
(thick line histogram) or without (thin line histogram) 20   μ  g/ml LAP for 
2 h at 4  °  C and analyzed for LAP expression. Isotype control is depicted 
with a solid gray histogram. (D) CD4  + CD25 +   T cells (5   ×   10  4 /well)  from 
lymph nodes of C57BL/6 mice were activated with plate-bound anti-CD3 
or with irradiated T cell  –  depleted splenocytes (5   ×   10  4  /well) and 0.25   μ  g/ml 
of soluble anti-CD3 in the presence or absence of LAP. [  3 H]TdR  incorpor-
ation was determined after 72 h of culture. (E) CD4  + CD25 +   from  C57BL/6 
mice or CD4  + CD25 +   GFP +   T cells from C57BL/6 FoxP3-GFP knock-in mice 
were cultured together with irradiated T cell  –  depleted splenocytes (5   ×   10  4 /
well) and 0.25   μ  g/ml of soluble anti-CD3 in the presence or absence of 
LAP. [  3  H]TdR incorporation was determined after 72 h of culture. 
(F) CD4  + CD25        C57BL/6 T cells (5   ×   10  4  /well) were co-cultured with 
CD4  + CD25 +   T cells from C57BL/6 mice (squares) or with CD4  + CD25 + GFP  +   T 
cells from C57BL/6 FoxP3-GFP knock-in mice (circles) in the presence of 
irradiated T cell  –  depleted splenocytes (5   ×   10  4  /well) and 0.25   μ  g/ml of 
soluble anti-CD3 with (open symbols) or without (closed symbols) 
12.5   μ  g/ml LAP. [  3  H]TdR incorporation was determined after 72 h of culture. 
One representative experiment of at least three is shown (A  –  F).     JEM VOL. 205, September 1, 2008  1977
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of LAP on the preactivated T reg cells. The low number of 
FoxP3  +   cells induced by fresh T reg cells is likely due to the 
induction of membrane-bound LAP  –  TGF-      when these cells 
become activated in the co-culture, but could potentially also 
be due to subpopulations of T reg cells expressing low levels of 
TGF-      on their cell surface. Cell contact was required for the 
T reg cell  –  dependent induction of FoxP3 because activated 
T reg cells separated from the naive responders using a tran-
swell system failed to induce FoxP3 (  Fig. 2 B  ). Induction of 
FoxP3 expression was also seen in the co-cultures of responder 
TCR transgenic T cells stimulated with their cognate peptide 
and activated polyclonal T reg cells, indicating that the TCR 
restimulation of the T reg cells was not required for FoxP3 
induction (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20080308/DC1). T reg cells generated in vitro 
by TCR stimulation of naive cells in the presence of IL-2 and 
TGF-      could also induce FoxP3 expression in naive cells, sug-
gesting that the T reg cell  –  dependent induction of FoxP3 can 
function in a positive feedback loop capable of inducing more 
suppressive T reg cells (Fig. S4). It should be noted that we 
have not seen any diff  erences in FoxP3 induction whether the 
T reg cells, responder T cells, and APCs are MHC matched or 
mismatched (unpublished data). 
  Culture of mouse T cells in the presence of TGF-      and 
IL-2 results in the induction of FoxP3 expression in a high 
percentage of the cells, and these induced T reg cells are 
fully functional in vitro and in vivo (  14, 15, 27  ). Because ac-
tivated T reg cells express LAP  –  TGF-      complexes on their 
cell surface, we asked whether T reg cells would be able to 
confer infectious tolerance by inducing FoxP3 expression in 
CD4  +  FoxP3         T cells. CD4  +  CD25  +  FoxP3  +   from FoxP3-GFP 
transgenic mice were activated with plate-bound anti-CD3 
and IL-2 for 3 d, followed by 1 d of culture in IL-2  –  con-
taining media. The activated T cells were then mixed with 
CFSE-labeled 5CC7 TCR transgenic RAG       /       T cells, which 
are completely devoid of FoxP3-expressing cells, and co-cul-
tured for 4 d in the presence of IL-2, anti-CD3, and splenic 
DCs. The addition of IL-2 was necessary for dampening the 
growth-suppressive eff  ects of the T reg cells and facilitating 
the recovery of live cells at the end of the co-culture. Co-cul-
ture of preactivated FoxP3  +   T reg cells, but not preactivated 
CD4  +  FoxP3         T cells, with naive CD4  +  FoxP3         T cells re-
sulted in the induction of FoxP3 expression in 10  –  30% of the 
naive T cells (  Fig. 2 A  ).   Freshly isolated T reg cells were much 
less effi   cient at inducing FoxP3 than previously activated T reg 
cells ( Fig. 2 B ), and this correlates with the increased expression 
    Figure 2.         T reg cells confer infectious tolerance in a TGF-      –  dependent manner.   (A) Activated CD4  + CD25      FoxP3      ,  CD4 + CD25 + FoxP3      ,  and 
CD4  + CD25 + FoxP3 +   T cells were co-cultured with CFSE-labeled 5CC7 TCR transgenic RAG      /      T cells, 2   μ  g/ml anti-CD3, splenic DCs, and IL-2 (100 U/ml) 
in the absence or presence of LAP. (B) Activated CD4  + CD25 +   and freshly isolated CD4  + CD25 +   were co-cultured with CFSE-labeled 5CC7 TCR trans-
genic RAG      /      T cells, 2   μ  g/ml anti-CD3, splenic DCs, and IL-2 (100 U/ml) (left panels). Activated CD4  + CD25 +   T cells were co-cultured with the re-
sponders or separated from the responders in a transwell (right panel). (C) Activated CD4  + CD25 +   T cells from the thymus of 2-wk-old TGF-    1     /     
mice or from littermate controls were co-cultured with CFSE-labeled 5CC7 TCR transgenic RAG      /      T cells. (D) Activated CD4  + FoxP3 +   T cells from 
peripheral lymph nodes of CD4cre-fur  f/f   mice or littermate controls were co-cultured with CFSE-labeled 5CC7 TCR transgenic RAG      /      T cells. Flow 
cytometric analysis was used to determine the level of FoxP3 expression after 4 d of the co-culture. All dot plots were gated on CFSE  +   cells  as 
shown in Fig. S2. One representative experiment out of at least two experiments is shown (A  –  D). Fig. S2 is available at http://www.jem.org/cgi/content/
full/jem.20080308/DC1.   1978 T REG CELLS CONFER INFECTIOUS TOLERANCE IN A TGF-       –  DEPENDENT MANNER   | Andersson et al. 
or without preactivated HA-specifi  c activated T reg cells. 
48 h after immunization,     10% of the CFSE-labeled naive 
CD4  +  CD25        CD44         T cells expressed FoxP3 (  Fig. 4 D  ). 
  Although TGF-      can be produced by many diff  erent cell 
types and has pleiotropic eff  ects on many diff  erent tissues, re-
cent studies suggest that TGF-      production by FoxP3  +   T reg 
cells plays a unique role in the maintenance of self-tolerance 
(  16  ). Although TGF-      secreted by T reg cells might suppress 
immune responses in an endocrine fashion, our studies and 
those of others strongly suggest that TGF-      is synthesized 
during T reg cell activation, processed by furin, secreted 
complexed to LAP, and maintained on the surface of the T 
reg cells as a LAP  –  TGF-      complex (  18, 19  ). Although some 
studies suggested that free TGF-      or LAP  –  TGF-      complexes 
could be detected on the surface of resting T reg cells (  19  ), 
we were only able to detect LAP on the surface of either 
  To formally prove that the T reg cell  –  dependent induc-
tion of FoxP3 was dependent on TGF-     , we co-cultured ac-
tivated T reg cells with naive T cells in the presence of IL-2, 
anti-CD3, splenic DCs, and rLAP. The addition of rLAP 
completely inhibited the induction of FoxP3, demonstrating 
that T reg cell  –  dependent induction of FoxP3 is TGF-      de-
pendent (  Fig. 2 A  ). To determine the cellular source of TGF-     , 
we isolated CD4  +  CD25  hi   T cells from the thymus of very 
young TGF-     1       /       mice. The majority of these cells remain 
FoxP3  +   during the co-culture (    80%) but fail to induce 
FoxP3 expression (  Fig. 2 C  ). Further evidence that the T reg 
cells themselves are the source of the TGF-      was obtained by 
using activated CD4  +  FoxP3  +   T cells from CD4cre-fur  f/f   mice 
that lack proprotein convertase furin expression in all T cells. 
These mice phenocopy mice lacking TGF-     1 expression in 
T cells and are incapable of processing TGF-     . T reg cells 
from these mice were markedly ineffi   cient in inducing FoxP3 
expression in T reg cells (  Fig. 2 D   and   28  ). 
  These studies strongly suggest that TCR activation in-
duces the synthesis of LAP  –  TGF-      that is then secreted and 
bound to the surface of the T reg cells.      V integrins ex-
pressed on DCs play a critical role in the binding of an RGD 
motif in LAP  –  TGF-      and in the subsequent activation of la-
tent TGF-      (  29  ). To determine if      V integrins were involved 
in the binding and/or activation of LAP  –  TGF-      on T reg 
cells, we activated T reg cells in the presence of anti-     V or in 
the presence of the RGDS peptide, both of which would 
block the binding and subsequent activation of LAP by      V. 
Addition of these reagents to either the fi  rst culture (not de-
picted) or to both the fi  rst and second cultures had no eff  ect 
on the capacity of activated T reg cells to induce FoxP3 ex-
pression in naive responder T cells. Furthermore, the pres-
ence of DCs was not required, as T reg cell activation and the 
induction of FoxpP3 expression could be induced in the 
presence of plate-bound anti-CD3 in the complete absence 
of APCs (  Fig. 3  ).   
  FoxP3 expression in mouse CD4  +   T cells correlates with 
a suppressive phenotype. To determine if CD4  +  FoxP3  +   T 
cells converted from naive T cells by co-culture with T reg 
cells were suppressive, we isolated CD4  +  FoxP3         T cells from 
FoxP3-GFP knock-in mice, co-cultured them for 4 d with 
activated CD4  +  CD25  +   T cells from wild-type mice in the 
presence of plate-bound anti-CD3 and IL-2, and then isolated 
GFP  +   T cells (Fig. S5, available at http://www.jem.org/cgi/
content/full/jem.20080308/DC1). The induced CD4  +  GFP  +   
T cells were markedly suppressive when mixed with naive 
responders and stimulated with anti-CD3 (  Fig. 4 A  ).   More 
importantly, the induced CD4  +  FoxP3  +   CD4  +   T cells could 
inhibit the development of colitis when cotransferred into 
RAG       /       mice with CD4  +  CD25        FoxP3         T cells (  Fig. 4, 
B and C  ). To evaluate whether activated FoxP3  +   T reg cells 
are capable of inducing FoxP3 expression in naive T cells in 
a more physiological setting in vivo, we transferred naive, 
CFSE-labeled CD4  +  CD25       CD44         (  <  0.5% FoxP3  +  ) TCR 
transgenic T cells that recognize hemagglutinin (HA)  110          –  119   
in association with I-E  d   into wild-type syngeneic mice with 
    Figure 3.         The induction of FoxP3 expression by activated T reg 
cells is APC and       v   integrin independent.   (A)  CD4 + CD25        (left)  and 
CD4  + CD25 +   (right) T cells from B10.A mice were activated for 4 d with 
plate-bound anti-CD3 and IL-2 (100 U/ml). The activated T cells were then 
co-cultured for an additional 4 d with an equal number of CFSE-labeled 
CD4  +   T cells from 5CC7 TCR transgenic RAG      /      mice in the presence of 
plate-bound anti-CD3 and IL-2. (B and C) CD4  + CD25 +   T cells were acti-
vated with plate-bound anti-CD3 and IL-2 for 4 d in the absence (left) or 
the presence (right) of blocking anti-     v   monoclonal  antibodies  (50   μ g/ml), 
RGE peptide, or RGD peptide (10   μ  g/ml). The activated cells were then co-
cultured with CFSE-labeled 5CC7 TCR transgenic T cells co-cultured in the 
presence or absence of the same inhibitors used in the fi  rst culture. FoxP3 
expression was determined on day 4 of the co-culture. One representative 
experiment out of at least three is shown (A  –  C).     JEM VOL. 205, September 1, 2008  1979
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deletion of TGF-      are fully competent suppressors in vitro 
(  16, 18, 24  ), whereas others have claimed that T reg cell sup-
pression in vitro can be reversed by anti  –  TGF-      (  19  ) or LAP 
(  18  ). Our results demonstrate that T reg cell  –  produced TGF-      
selectively inhibits the activation of CD4  +  CD25  +  FoxP3         
T cells, but it is not needed for inhibiting the activation of 
CD4  +  CD25        FoxP3         T cells. During an immune response, 
many eff  ector cells express CD25 and it is thus possible that 
TGF-      plays an important role as a suppressor eff  ector mech-
anism at sites of infl  ammation. As preparations of CD4  +  CD25  +   
T cells, particularly from the spleen, contain variable num-
bers of CD4  +  CD25  +  FoxP3         T cells, it remains possible 
that the partial reversal of the suppression mediated by 
CD4  +  CD25  +  Foxp3  +   in the presence of anti  –  TGF-      (  19  ) 
or LAP (  18  ) is secondary to reversal of the suppression of 
CD4  +  CD25  +  Foxp3         T cells by T reg cell  –  produced TGF-     . 
It is unclear why partially activated CD4  +  CD25  +  FoxP3         T 
cells would be uniquely susceptible to T reg cell  –  produced 
TGF-     , as they have similar levels of TGF-      receptors when 
compared with naive CD4  +   T cells (unpublished data). We 
also believe that this study strongly favors the view that T reg 
cells use more than one mechanism of suppression (  30  ), and 
it appears that the activation state of the responder T cells 
may also infl  uence the specifi  c suppressor pathway used. 
  The potential contribution of T reg cell  –  produced TGF-      
to suppression in vivo has also been diffi   cult to dissect. We 
and others (  25, 26  ) have shown that T reg cells from TGF-
            /       mice are fully capable of suppressing the induction of 
infl  ammatory bowel disease by CD45RB  hi   or CD4  +  CD25         
T cells in vivo. On the other hand, more recent studies have 
shown that mice with T cell  –  specifi  c defi  ciencies in TGF-      
production (  16  ) or processing (unpublished data) gradually 
lose self-tolerance and develop infl  ammatory bowel disease. 
At present, we can only speculate on the diff  erences between 
these studies, but they may be related to diff  erences in the 
bacterial fl  ora in diff  erent colonies and the severity of the in-
fl  ammatory milieu in the gut. T reg cell  –  mediated FoxP3 in-
duction appears to be tightly regulated and dependent on T 
reg cell activation. It is therefore likely that T reg cell  –  medi-
ated FoxP3 induction would be most prominent at sites of 
signifi  cant infl  ammation such as the gastrointestinal tract or in 
allografts undergoing chronic rejection. In addition, the mi-
croenvironment may play an important role in controlling 
the balance between T reg cell induction and the induction 
of Th17 cells, as T reg cell production of TGF-      in associa-
tion with IL-6 may induce eff  ector Th17 cells (  31  ). Although 
we could not defi  ne a role for DCs in the induction of FoxP3 
in vitro, in vivo, simultaneous stimulation of both the T reg 
cells and antigen-specifi  c T cells likely occurs on the platform 
of a DC in the form of a three-cell interaction. As a single 
DC can present more than one organ-derived antigen, it 
is possible that the T reg cell  –  TGF-      pathway of FoxP3 
induction can result in expansion of T reg cells of broad anti-
gen specifi  cities and thus serve as an important adjuvant in 
the use of T reg cells for cellular biotherapy in autoimmunity 
and transplantation. 
activated mouse or human FoxP3  +   T reg cells. Technical dif-
ferences in the purifi  cation and assays for cell surface LAP 
may account for the diff  erences between these studies. 
  The contribution of T reg cell  –  produced TGF-      to the 
inhibition of the proliferation of CD4  +  CD25         T cells in co-
cultures in vitro has remained controversial (  17  –  19, 24  ). We 
and others have previously demonstrated that CD4  +  CD25  +   
T cells from TGF-            /       mice or mice with a T cell  –  specifi  c 
    Figure 4.         Induced FoxP3  +   T cells are suppressive in vitro and 
in vivo.   (A) T reg cell  –  induced CD4  + FoxP3 +   T cells (open squares) were iso-
lated as in Fig. S5 and tested for suppressive ability by co-culturing them 
with CD4  + CD25        T cells (5   ×   10  4  /well) in the presence of irradiated T 
cell – depleted  splenocytes  (5   ×   10 4  /well) and 0.25   μ  g/ml of soluble anti-
CD3. Activated CD4  + CD25      GFP        T cells (closed squares) from C57BL/6 
FoxP3-GFP mice were used as controls. Proliferation was measured by 
the incorporation of [  3  H]TdR after 72 h of culture. (B) CD4  + GFP        T  cells 
(5   ×   10 5  ) from C57BL/6 FoxP3-GFP knock-in mice were transferred into 
C57BL/6 RAG      /      mice with or without 1.5   ×   10  5   T  reg  cell – induced 
FoxP3  +   T cells isolated as described in Fig. S5. The weight of all recipi-
ents was measured at 6 wk after cell transfer. P   <   0.006 using Student  ’  s 
  t   test. (C) Hematoxylin and eosin  –  stained tissue sections from the colon 
of C57BL/6 RAG      /      mice that received CD4  + FoxP3        T cells with (right) or 
without (left) the addition of T reg cell  –  induced CD4  + FoxP3 +   T cells. Bar, 
100   μ  m. (D) CFSE-labeled CD4  + CD25      CD44        HA TCR transgenic T cells 
(0.5   ×   10 6  ) were transferred into B10.D2 mice with or without activated 
HA-specifi  c TCR transgenic T reg cells (2.5   ×   10  6  ). 1 d later, all recipients 
were immunized with HA peptide in IFA, and draining lymph node cells 
were analyzed for FoxP3 expression 48 h after transfer. One representa-
tive experiment out of at least two is shown (A  –  D). Fig. S5 is available at 
http://www.jem.org/cgi/content/full/jem.20080308/DC1.   1980 T REG CELLS CONFER INFECTIOUS TOLERANCE IN A TGF-       –  DEPENDENT MANNER   | Andersson et al. 
induced T reg cells are capable of inducing FoxP3 expression. Fig. S5 shows 
the purity of induced CD4  +  FoxP3  +   T cells after isolation using cell sort-
ing. The online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20080308/DC1. 
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